Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy.

Clinical breast cancer

Volumn 5, Issue 6, 2005, Pages 439-446

  O'Shaughnessy, Joyce A ^a   Vukelja, Svetislava J ^a   Holmes, Frankie Ann ^a   Savin, Michael ^a   Jones, Monte ^a   Royall, Donald ^a   George, Martine ^a   Von Hoff, Daniel ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; PLACEBO; RECOMBINANT ERYTHROPOIETIN;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AFFECT; AGED; ARTICLE; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FATIGUE; FEMALE; HUMAN; MIDDLE AGED; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADULT; AFFECT; AGED; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COGNITION DISORDERS; DOUBLE-BLIND METHOD; EPOETIN ALFA; FATIGUE; FEMALE; HEMATINICS; HUMANS; INJECTIONS, SUBCUTANEOUS; MIDDLE AGED; NEOADJUVANT THERAPY; PLACEBOS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 18744401355     PISSN: 15268209     EISSN: None     Source Type: Journal    
DOI: 10.3816/CBC.2005.n.002     Document Type: Article

References (0)